Erik Mickels Sells 3,334 Shares of MarketWise (NASDAQ:MKTW) Stock

MarketWise, Inc. (NASDAQ:MKTW) CFO Erik Mickels sold 3,334 shares of the company’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $15.20, for a total transaction of $50,676.80. Following the completion of the transaction, the chief financial officer owned 63,103 shares in the company, valued at approximately $959,165.60. This represents a 5.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Erik Mickels also recently made the following trade(s):

• On Wednesday, March 11th, Erik Mickels sold 6,666 shares of MarketWise stock. The shares were sold at an average price of $14.73, for a total transaction of $98,190.18.

MarketWise Stock Performance

NASDAQ MKTW opened at $14.15 on Friday. The stock has a market cap of $226.82 million, a PE ratio of 6.18 and a beta of 0.55. The firm has a 50-day moving average of $15.24 and a 200-day moving average of $15.80. MarketWise, Inc. has a 52-week low of $9.07 and a 52-week high of $21.74.

MarketWise (NASDAQ:MKTW) last announced its quarterly earnings results on Friday, March 6th. The newsletter publisher reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.99. The business had revenue of $83.39 million for the quarter, compared to analyst estimates of $70.60 million. MarketWise had a net margin of 1.71% and a negative return on equity of 2.54%.

MarketWise Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Wednesday, March 18th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date is Wednesday, March 18th. MarketWise’s payout ratio is currently 34.93%.

Analyst Ratings Changes

MKTW has been the topic of a number of recent research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of MarketWise in a research note on Thursday, January 22nd. UBS Group restated an “outperform” rating on shares of MarketWise in a research note on Monday, November 24th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, MarketWise presently has a consensus rating of “Hold” and a consensus price target of $20.00.

Institutional Trading of MarketWise

Institutional investors have recently bought and sold shares of the business. Russell Investments Group Ltd. acquired a new position in shares of MarketWise during the 2nd quarter worth approximately $28,000. Wells Fargo & Company MN increased its holdings in shares of MarketWise by 52.5% during the fourth quarter. Wells Fargo & Company MN now owns 2,199 shares of the newsletter publisher’s stock worth $33,000 after purchasing an additional 757 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of MarketWise in the second quarter valued at approximately $226,000. Susquehanna International Group LLP acquired a new stake in shares of MarketWise in the third quarter valued at approximately $191,000. Finally, Renaissance Technologies LLC boosted its stake in shares of MarketWise by 4.7% in the fourth quarter. Renaissance Technologies LLC now owns 19,899 shares of the newsletter publisher’s stock valued at $299,000 after buying an additional 900 shares during the period. Institutional investors own 23.04% of the company’s stock.

MarketWise Company Profile

MarketWise, Inc operates a content and technology multi-brand platform for self-directed investors in the United States and Internationally. Its platform includes subscription businesses that provides financial research, software, education, and tools to navigate the financial markets. The company offers various investment strategies, such as value investing, income, growth, commodities, cryptocurrencies, venture, crowdfunded investing, biotechnology, mutual funds, options, and trading; investment research product portfolio through a range of media, including desktops, laptops, tablets, and mobile; and financial newsletters.